The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
about
Pertuzumab in combination with trastuzumab and docetaxel for the treatment of HER2-positive metastatic or locally recurrent unresectable breast cancerAssociation of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).Feasibility study for collection of HER2 data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program central cancer registries.Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer.The influence of nativity and neighborhoods on breast cancer stage at diagnosis and survival among California Hispanic womenBreast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.Distinct breast cancer subtypes in women with early-onset disease across racesT cell coinhibition and immunotherapy in human breast cancerBreast cancer characteristics and survival in a Hispanic population of costa rica.Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?Minireview: Basal-like breast cancer: from molecular profiles to targeted therapiesDisparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white womenTriple-negative breast cancer: adjuvant therapeutic options.Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of ageAnalysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China.The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.A Comparison of Clinical Features, Pathology and Outcomes in Various Subtypes of Breast Cancer in Indian Women.Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study.Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations.Association between body mass index and breast cancer intrinsic subtypes in Japanese women.Integration of molecular pathology, epidemiology and social science for global precision medicine.Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico.Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer RegistryTriple-negative breast cancers are increased in black women regardless of age or body mass indexEpidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors.Exposure-response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parameters.Supporting Asian patients with metastatic breast cancer during ixabepilone therapy.A review of body size and breast cancer risk in Hispanic and African American women.Triple-negative breast cancer: epidemiological considerations and recommendations.Therapies for triple negative breast cancer.Regional Variation in Disparities in Breast Cancer Specific Mortality Due to Race/Ethnicity, Socioeconomic Status, and Urbanization.Breast cancer survival in African-American women by hormone receptor subtypes.Black Rice Anthocyanins Suppress Metastasis of Breast Cancer Cells by Targeting RAS/RAF/MAPK Pathway.Differential patterns of recurrence and specific survival between luminal A and luminal B breast cancer according to recent changes in the 2013 St Gallen immunohistochemical classification.
P2860
Q28246333-3E1A7A34-02FF-4A4A-9F7A-54E8D26ABD54Q30813968-2BE55243-24B0-49F8-91F2-6B71F189D522Q33522516-5A828822-6B32-4B9A-BCC1-66728650946DQ33563273-9C447DA5-A2FE-4B61-BE49-32281CB09792Q33584305-218EBE7C-2F65-4401-8A06-5CF4319542CFQ33584322-C128518D-9AA7-45F1-9953-5D04F742918AQ33738268-B5740C09-F1D1-4AF7-81CF-4FC3438119E2Q33757796-4772F6AA-D1F4-469C-B5DF-5AB4DCACBDB0Q33932660-AFA14E37-E342-415C-A52D-C6D34F439357Q33936154-74984E3E-F5A7-425A-A42A-CFF6B3F8D7B3Q34016474-46106863-20D5-41A4-AD31-B5A508C0EE07Q34134876-F62D56E2-124B-4A10-9F9A-E9956F24E3C3Q34562257-BE9E3606-BDB4-4810-9245-CA4C2CF138FDQ35003673-3CAA7D2A-35E2-40C3-A002-48BDDBED1DBBQ35267097-F39663F4-7C92-4B6B-96F8-AC685503462BQ35692146-6BC8B778-4DF8-42E3-8DE8-134D923019C7Q35894901-0C43D921-6469-4173-8BF0-B16147380F3BQ35909551-4A1F573C-EA67-44B6-9473-07931B522EEAQ35962877-6E5F1580-45C3-4C4E-A54F-20E9D4AA5EA8Q36163073-0139C8FB-8875-48E2-BE00-4691E99E03C0Q36226056-0EDEF4C2-7557-49A2-BEBE-53A026CA41CBQ36281065-09958355-5407-43D2-8540-457792489EC1Q36288288-908F5760-9462-4615-9F86-274EC06D8DD5Q36415887-DFC3FCDC-FFDF-49A7-BD36-DE6A3B7E87E3Q36463854-CD9FB01F-1AEC-4CF2-880A-C97F212F02F2Q36542202-3716906C-378D-40B2-9E9A-0882A6A9FD34Q36603829-F189FBFE-DC95-4F19-B27B-84929A2E4C3DQ36977429-D3FD8F35-0477-4DFC-9435-976DE51CA8C8Q37205563-045BBDAC-A5BB-41AA-8BD2-8EE7EA7D98C0Q37208769-38B2CA28-B3B3-4C92-BCAF-DFCF95507DC5Q37277141-EE52D1EC-2CA8-4F68-B0F8-985BE27B6A47Q37302085-9E105569-04CD-4E06-8AB9-C00D829551CAQ37682258-71216732-6AAD-4CCB-97A1-4A6073673C7AQ37877651-5D0D8454-0E5B-45AF-9B20-95BC15A9FBE4Q38046586-49061F65-6E7E-4A4A-9FF2-86108FD8EF21Q38424397-697C11B0-2082-4F04-ACE7-C1DB8C0C6374Q39338518-10BA51C1-0A69-4C51-B7B1-D69B36496A32Q40650720-52414FEC-B90E-497C-8EE6-901B6D5404EBQ41832196-82A658AA-CDE6-4EFD-B93B-1DB2C95B33C2Q43790330-1B9BDD3A-76A2-4755-9E2D-9FA73D11999F
P2860
The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The role of human epidermal gr ...... ia Cancer Registry, 1999-2004.
@en
The role of human epidermal gr ...... ia Cancer Registry, 1999-2004.
@nl
type
label
The role of human epidermal gr ...... ia Cancer Registry, 1999-2004.
@en
The role of human epidermal gr ...... ia Cancer Registry, 1999-2004.
@nl
prefLabel
The role of human epidermal gr ...... ia Cancer Registry, 1999-2004.
@en
The role of human epidermal gr ...... ia Cancer Registry, 1999-2004.
@nl
P2093
P2860
P356
P1433
P1476
The role of human epidermal gr ...... ia Cancer Registry, 1999-2004.
@en
P2093
Alex Tsodikov
Carol A Parise
Katrina R Bauer
Monica Brown
Vincent Caggiano
P2860
P304
P356
10.1002/CNCR.23243
P407
P577
2008-02-01T00:00:00Z